Bradykinin B1and B2receptors, Tumour Necrosis Factorαand Inflammatory Hyperalgesia

British Journal of Pharmacology- United States

doi 10.1038/sj.bjp.0702347

Full Text

Abstract

Available in

Categories

Pharmacology

Date

Authors

Publisher

Wiley

Related search

Bradykinin Initiates Cytokine-Mediated Inflammatory Hyperalgesia

British Journal of Pharmacology
Pharmacology
1993English

Antagonist, Partial Agonist and Antiproliferative Actions of B-9870 (CU201) as a Function of the Expression and Density of the Bradykinin B1and B2receptors

British Journal of Pharmacology
Pharmacology
2007English

Agonist-Independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2Receptors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Protease-Activated Receptors and Inflammatory Hyperalgesia

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2005English

Inflammatory Myofibroblastic Tumour

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Phosphorylation of the Small Heat-Shock Protein Is Regulated by Interleukin 1, Tumour Necrosis Factor, Growth Factors, Bradykinin and ATP

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1991English

Polymorphisms in the Tumour Necrosis Factor Gene Are Not Associated With Severity of Inflammatory Polyarthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
2010English

Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy